The Cancer Therapies Market in Europe is being driven by Increased prevalence of cancer
The Cancer Therapies Market in Europe is expected to grow at a CAGR of 6.7% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 28.6 billion. In the European cancer therapies market, vendors are making significant investments in research and development to introduce innovative diagnostic devices for cancer detection and treatment. One such groundbreaking approach is the development of nanoparticle-based cancer theranostics utilizing gold nanoparticles. This technique integrates both a therapeutic and diagnostic agent with gold nanoparticles, enabling effective monitoring of target tumors and offering valuable insights into the impact of cancer drugs on the tumor. The market is expected to witness increased demand for these theranostic combined therapeutics upon their launch and availability, consequently boosting the usage of cancer diagnostic devices.
Get more information on Cancer Therapies Market in Europe by requesting a sample report
Which Factors Are Causing a Surge in Market Growth?
The market is segmented based on Type (Chemotherapy, Targeted therapy, Immunotherapy, Others) Geography (Europe).
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Key Features in Cancer Therapies Market in Europe Research Report
Find out which segment is leading the market by accessing the free PDF report
The European cancer therapeutics market is experiencing significant growth due to the increasing prevalence of cancer, with new cases and deaths on the rise among the geriatric population. Advanced cancer therapies, including targeted drugs and diagnostic techniques for early detection, are driving innovation in cancer treatment. Healthcare providers and specialty clinics are adopting telehealth and virtual medicine to improve access to oncologists and specific therapeutics for newly diagnosed and conventionally treated cancer patients. Pharmaceutical companies are investing heavily in drug development for cancer therapeutics, focusing on specific therapeutics for various types of cancer. Cancer research continues to play a crucial role in developing new treatments and improving patient outcomes.
The European Cancer Therapies Market is a significant segment of the larger European healthcare industry, encompassing entities involved in research, development, and manufacturing of targeted drugs, diagnostic techniques, and specialized cancer treatments. This market's growth is driven by several factors, including the increasing prevalence of cancer, the rise in healthcare expenditures, and the expansion of specialty clinics and cancer research centers. Volastra Therapeutics, a leading player in this sector, recently secured Series A funding to advance its pipeline of innovative oncology therapies. The European market's growth is further fueled by the aging population trend, with Europe projected to reach a population ratio of over 25% aged 60 years or above by 2030, similar to the US's predicted demographic shift by 2050. This demographic change, coupled with advancements in diagnostic techniques and targeted drug development, positions the European Cancer Therapies Market for substantial growth in the coming years.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
